Devimistat (CPI-613)

Devimistat (CPI-613), a lipoate analog, inhibits mitochondrial enzymes pyruvate dehydrogenase (PDH) and α-ketoglutarate dehydrogenase in NCI-H460 cell line, disrupts tumor cell mitochondrial metabolism. CPI-613 induces apoptosis in pancreatic cancer cells. Phase 2.

Price Not Available 50mg Devimistat (CPI-613) Supplier Page

Trivial name	N/A
Catalog Number	S2776
Molecular Formula	C26H21N3O3
CAS#	95809-78-2
Inchi	InChI=1S/C26H21N3O3/c30-20-10-6-18(7-11-20)15-23-26(32)29-16-24(19-8-12-21(31)13-9-19)27-22(25(29)28-23)14-17-4-2-1-3-5-17/h1-13,16,27,30-31H,14-15H2
Inchi Key	YHIPILPTUVMWQT-UHFFFAOYSA-N
SMILES	C1=CC=C(C=C1)CC2=NC(=CN3C2=NC(=C3O)CC4=CC=C(C=C4)O)C5=CC=C(C=C5)O
Size	50mg
Supplier Page	http://www.selleckchem.com/products/cpi-613.html
Additional Information	https://file.selleck.cn/downloads/struct/CPI-613-chemical-structure-s2776.gif